Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Goldstein

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Cancer Research|October 3, 2018
Innervation of the Tumor Microenvironment-LetterMark R Goldstein, Luca Mascitelli
Giornale Italiano Di Cardiologia (2006)|December 16, 2015
[The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints]Luca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|June 25, 2016
Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?Luca Mascitelli, Mark R Goldstein
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2014
Androgen receptor-dependent variation in PSA--letterMark R Goldstein, Luca Mascitelli
Maturitas|December 3, 2010
Menopause, estrogen, statins, and the immune systemLuca Mascitelli, Mark R Goldstein
Diabetes Research and Clinical Practice|March 29, 2011
Chronic lung diseases, diabetes and hypovitaminosis D: is there a connection? Comment on Song et al. [Diabetes Res. Clin. Pract. 90 (2010) 365-371]Luca Mascitelli, Mark R Goldstein
Hepatology (Baltimore, Md.)|May 25, 2011
Metabolic syndrome and liver cancer: is excess iron the link?Luca Mascitelli, Mark R Goldstein
Acta Diabetologica|April 19, 2011
Higher liver transaminase levels and oral hypoglycemic drug therapy failure in patients with type 2 diabetes: is iron the missing link?Luca Mascitelli, Mark R Goldstein
Neuroscience and Biobehavioral Reviews|July 23, 2022
Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"Mark R Goldstein, Luca Mascitelli
Annals of Internal Medicine|October 19, 2011
An update on the comparative effectiveness and safety of medications for type 2 diabetesMark R Goldstein, Luca Mascitelli
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Cancer Research|October 3, 2018
Innervation of the Tumor Microenvironment-LetterMark R Goldstein, Luca Mascitelli
Giornale Italiano Di Cardiologia (2006)|December 16, 2015
[The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints]Luca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|June 25, 2016
Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?Luca Mascitelli, Mark R Goldstein
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2014
Androgen receptor-dependent variation in PSA--letterMark R Goldstein, Luca Mascitelli
Maturitas|December 3, 2010
Menopause, estrogen, statins, and the immune systemLuca Mascitelli, Mark R Goldstein
Diabetes Research and Clinical Practice|March 29, 2011
Chronic lung diseases, diabetes and hypovitaminosis D: is there a connection? Comment on Song et al. [Diabetes Res. Clin. Pract. 90 (2010) 365-371]Luca Mascitelli, Mark R Goldstein
Hepatology (Baltimore, Md.)|May 25, 2011
Metabolic syndrome and liver cancer: is excess iron the link?Luca Mascitelli, Mark R Goldstein
Acta Diabetologica|April 19, 2011
Higher liver transaminase levels and oral hypoglycemic drug therapy failure in patients with type 2 diabetes: is iron the missing link?Luca Mascitelli, Mark R Goldstein
Neuroscience and Biobehavioral Reviews|July 23, 2022
Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"Mark R Goldstein, Luca Mascitelli
Annals of Internal Medicine|October 19, 2011
An update on the comparative effectiveness and safety of medications for type 2 diabetesMark R Goldstein, Luca Mascitelli
Pageof 20